King Bio Recalls Dr. King's SafeCare Rx Allergies Due to Microbial Contamination
King Bio Inc. is recalling Dr. King's SafeCare Rx Allergies Southwest U.S. due to microbial contamination. The recall covers 1,621 bottles distributed in the U.S., Canada, and Australia.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which corresponds to a Critical severity score of 5 per the rubric.
Plain-English summary
King Bio Inc. is recalling 1,621 bottles of Dr. King's SafeCare Rx Allergies Southwest U.S., 2 fl. oz. (59 mL). The product is identified by NDC 57955-2715-2 and UPC 357955175025. The recall is due to microbial contamination.
The affected lots are 030818A (Exp. 03/20), 011416B (Exp. 01/19), and 111016B (Exp. 11/19). The product was distributed nationwide in the U.S.A., as well as in Canada and Australia.
Consumers should stop using the product and contact King Bio Inc. for further instructions.
The recalled product
- Product
- Dr. King's SafeCare Rx Allergies Southwest U.S., 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955175025, NDC 57955-2715-2
- Manufacturer
- King Bio Inc.
- Category
- Drug — Homeopathic
- Hazard
- Affected units
- 1,621
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: 030818A Exp. 03/20
- 011416B Exp. 01/19
- 111016B Exp. 11/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 465 recalled by King Bio Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 465 products in this recall →Related recalls
Same manufacturer · King Bio Inc.
See all →- CriticalKing Bio Recalls Dr. King's SafeCare Rx Calloused Due to Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Spray Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalKing Bio Recalls Heartburn Relief for Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Product Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalDr. King's Advanced Arnica Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereMuscle Rage King Test Capsules Recalled for Undeclared Milk
FDA (Food) · 2022-01-19
- SevereSafecor Health Recalls Doxycycline Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2017-06-21
- SevereWestern Drug Recalls VitB12/VitC/VitB3/VitB9 Injections Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereDowning Labs Recalls B12 Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SevereWestern Drug Recalls B-12 and B6 Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls AMP50/B121MG Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09